Browsing by Author Pentheroudakis, G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 104  next >
TitleAuthor(s)Issue date
Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidencePentheroudakis, G.; Lazaridis, G.; Pavlidis, N.24-Nov-2015
Bevacizumab in ovarian cancerMountzios, G.; Pentheroudakis, G.24-Nov-2015
Biweekly administration of 24-h infusion of irinotecan followed by a 1-h infusion of docetaxel: a phase I studyBriasoulis, E.; Pentheroudakis, G.; Timotheadou, H.; Rammou, D.; Pavlidis, N.; Fountzilas, G.24-Nov-2015
Can circulated lung cancer cells pass to the urine without apparent urine tract metastases? A single centre seriesKamposioras, K.; Pentheroudakis, G.; Malamou-Mitsi, V.; Pappa, L.; Bafa, M.; Pavlidis, N.24-Nov-2015
Cancer and pregnancyPentheroudakis, G.24-Nov-2015
Cancer and pregnancy: a comprehensive reviewVoulgaris, E.; Pentheroudakis, G.; Pavlidis, N.24-Nov-2015
Cancer and pregnancy: poena magna, not anymorePentheroudakis, G.; Pavlidis, N.24-Nov-2015
Cancer of unknown primary patients with midline nodal distribution: midway between poor and favourable prognosis?Pentheroudakis, G.; Stoyianni, A.; Pavlidis, N.24-Nov-2015
Cancer of unknown primary sitePavlidis, N.; Pentheroudakis, G.24-Nov-2015
Cancer of unknown primary site: 20 questions to be answeredPavlidis, N.; Pentheroudakis, G.24-Nov-2015
Cancer of unknown primary site: missing primary or missing biology?Pentheroudakis, G.; Briasoulis, E.; Pavlidis, N.24-Nov-2015
Cancer of unknown primary: what kind of chemotherapy? What kind of disease?Pentheroudakis, G.; Pavlidis, N.24-Nov-2015
Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upPentheroudakis, G.; Orecchia, R.; Hoekstra, H. J.; Pavlidis, N.24-Nov-2015
Cancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-upPentheroudakis, G.; Pavlidis, N.; Castiglione, M.24-Nov-2015
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upPavlidis, N.; Briasoulis, E.; Pentheroudakis, G.24-Nov-2015
Capecitabine (Xeloda): from the laboratory to the patient's homePentheroudakis, G.; Twelves, C.24-Nov-2015
Cavitating squamous cell lung carcinoma-distinct entity or not? Analysis of radiologic, histologic, and clinical featuresPentheroudakis, G.; Kostadima, L.; Fountzilas, G.; Kalogera-Fountzila, A.; Klouvas, G.; Kalofonos, C.; Pavlidis, N.24-Nov-2015
Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUPPavlidis, N.; Pentheroudakis, G.; Plataniotis, G.24-Nov-2015
Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?Pentheroudakis, G.; Briasoulis, E.; Karavassilis, V.; Fountzilas, G.; Xeros, N.; Samelis, G.; Samantas, E.; Pavlidis, N.24-Nov-2015
Colorectal cancer screening awareness in European primary careMauri, D.; Pentheroudakis, G.; Milousis, A.; Xilomenos, A.; Panagoulopoulou, E.; Bristianou, M.; Zacharias, G.; Christidis, D.; Mustou, E. A.; Gkinosati, A.; Pavlidis, N.24-Nov-2015